MedTrace Logo

Copeptin in the Diagnosis and Differential Diagnosis of Diabetes Insipidus. The CoSIP-Study

NCT00757276 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2014-12-15

No results posted yet for this study

Summary

Evaluation of Copeptin in the differential diagnosis of diabetes insipidus.

Conditions

  • Diabetes Insipidus

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Mirjam Christ-Crain, Prof. Dr. med. · University Hospital, Basel, Switzerland

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00757276 on ClinicalTrials.gov